Dr. Govindan on the Genomic Characterization of Large-Cell Neuroendocrine Lung Tumors

Ramaswamy Govindan, MD
Published: Monday, Sep 07, 2015



Ramaswamy Govindan, MD, medical oncologist, Siteman Cancer Center and Washington University School of Medicine in St. Louis, discusses a talk given at the 16th World Conference on Lung Cancer.

Govindan says he was struck by the fact that some samples of large-cell neuroendocrine lung tumors look like small cell lung cancer while others look like non-small cell lung cancer (NSCLC). These tumors typically present in smokers and lead to poor outcomes.

There remains a need, he says, to understand the biology of these cancers so they can be treated with biological and rational therapies.

<<< View more from the 2015 World Conference on Lung Cancer



Ramaswamy Govindan, MD, medical oncologist, Siteman Cancer Center and Washington University School of Medicine in St. Louis, discusses a talk given at the 16th World Conference on Lung Cancer.

Govindan says he was struck by the fact that some samples of large-cell neuroendocrine lung tumors look like small cell lung cancer while others look like non-small cell lung cancer (NSCLC). These tumors typically present in smokers and lead to poor outcomes.

There remains a need, he says, to understand the biology of these cancers so they can be treated with biological and rational therapies.

<<< View more from the 2015 World Conference on Lung Cancer




View Conference Coverage
Online CME Activities
TitleExpiration DateCME Credits
Community Practice Connections™: ALK-Positive NSCLC: Emerging Strategies to Inform Sequencing, Optimize Outcomes, and Address Unmet Clinical Needs Along the Disease ContinuumAug 29, 20181.5
Community Practice Connections™: Oncogenic Tumor Board in Advanced NSCLC: Leveraging Actionable Mutations Along the Disease Continuum to Optimize Patient OutcomesAug 30, 20182.0
Publication Bottom Border
Border Publication
x